Altimmune News

Altimmune Analyst Ratings

BenzingaApr 29 18:40

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Terns Pharmaceuticals (TERN) and Altimmune (ALT)

TipRanksApr 3 20:11

Altimmune Analyst Ratings

BenzingaApr 2 00:22

HC Wainwright & Co. Maintains Buy on Altimmune, Lowers Price Target to $12

BenzingaApr 2 00:23

Altimmune's Pemvidutide Shows Promise for Obesity Treatment, Justifying Buy Rating

TipRanksApr 2 00:15

Altimmune Analyst Ratings

BenzingaMar 28 23:55

Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Altimmune (ALT)

TipRanksMar 28 20:00

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Kiora Pharmaceuticals (KPRX) and Actinium Pharmaceuticals (ATNM)

TipRanksMar 28 19:30

Buy Rating Affirmed for Altimmune as Pemvidutide Shows Promising Weight Loss and Lean Mass Preservation

TipRanksMar 28 05:25

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Altimmune (ALT)

TipRanksMar 28 03:40

Altimmune's Pemvidutide Poised for Market Success: A Buy Rating With a $25 Price Target

TipRanksFeb 27 03:45

Analysts Conflicted on These Healthcare Names: Cogent Biosciences (COGT) and Altimmune (ALT)

TipRanksFeb 26 22:40

Altimmune (ALT) Gets a Buy From Piper Sandler

TipRanksFeb 15 21:55

Buy Rating for Altimmune Backed by Pemvidutide's Promise and Market Potential

TipRanksFeb 14 11:35

B. Riley Securities Maintains Buy on Altimmune, Announces $20 Price Target

BenzingaFeb 14 07:04

Altimmune Analyst Ratings

BenzingaFeb 14 07:01

Altimmune's Pemvidutide Shows Promising Outlook in NASH and Obesity Markets: A Strong Buy Rating

TipRanksFeb 7 04:15

Goldman Sachs Reinstates Neutral on Altimmune, Announces $13 Price Target

BenzingaJan 24 20:04

Altimmune Analyst Ratings

BenzingaJan 24 20:02

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), 10x Genomics (TXG) and Altimmune (ALT)

TipRanksJan 23 03:10